{"disease":{"id":"rheumatoid-arthritis-moderate-to-severe-active-disease","name":"rheumatoid arthritis moderate to severe active disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03357471","title":"Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}